English
简体中文
Total: £ 56.28
Published Date: 2025-12-13 | Pages: 69 | Tables: 74 | Pharma & Healthcare
The global market for Daridorexant was valued at US$ 69.19 million in the year 2024 and is projected to reach a revised size of US$ 831 million by 2031, growing at a CAGR of 29.8% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Daridorexant competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Daridorexant, sold under the brand name Quviviq, is a medication used to treat insomnia. It is an orexin receptor antagonist, specifically targeting both OX1 and OX2 receptors. This dual mechanism helps regulate sleep-wake cycles, making it effective for improving sleep onset and maintenance. Unlike benzodiazepines or Z-drugs, daridorexant does not interact with GABA receptors, offering a distinct way to manage sleep disorders.
The medication is taken orally and has a relatively short elimination half-life of around 8 hours, with a peak effect occurring within 1 to 2 hours after administration. Common side effects include headache, somnolence (sleepiness), and fatigue. Daridorexant was approved for use in the United States in January 2022 and became available in May 2022. It was also approved in the European Union in April 2022, marking the first orexin receptor antagonist to be available there. However, it is classified as a Schedule IV controlled substance in the United States, indicating a modest potential for misuse.
Daridorexant provides an alternative to traditional sleep medications, offering a distinct mechanism of action that may reduce the risk of dependence and tolerance associated with other sleep aids.In 2024, global sales of Daridorexant reached 3.94 million tablets, with an average unit price of USD 17.56 per tablet and an average gross profit margin of 71.2%.
In the U.S. and Europe, Daridorexant has entered a phase of rapid commercial expansion, supported by favorable clinical differentiation and growing physician adoption. Within the European Union, it is the most recent DORA approved by the EMA for improving both nighttime sleep and daytime functioning—an indication that broadens its clinical appeal beyond sleep onset and maintenance alone. Compared with other DORAs, its pharmacokinetic profile and well-balanced efficacy-safety ratio contribute to higher treatment adherence and positive real-world outcomes.
From a commercial standpoint, Daridorexant’s global rollout reflects a strategic blend of licensing, distribution, and market access initiatives. Regional partnerships enable efficient regulatory navigation and localized market penetration, ensuring coverage across hospitals, retail pharmacies, and online prescription platforms. Reimbursement listings in select countries further enhance patient accessibility, reinforcing uptake momentum. The integration of pharmacovigilance and patient-reported outcomes into post-marketing surveillance also supports sustained physician confidence and long-term safety validation.
Market uptake has been strongest in North America, Western Europe, and Japan, where supportive healthcare infrastructure and awareness campaigns accelerate adoption. In emerging markets such as China, Daridorexant’s entry underscores the expanding recognition of DORA-based therapeutics as the next-generation standard for insomnia care. Continued emphasis on education, real-world data generation, and stable supply chains will be critical to maintaining its growth trajectory.
Overall, Daridorexant exemplifies the evolution of insomnia therapeutics toward mechanism-driven, safety-conscious innovation. Its combination of differentiated pharmacology, robust clinical data, and strategic commercialization positions it as a leading agent in the global sleep medicine landscape—poised to define the post-benzodiazepine era of pharmacological sleep management.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Daridorexant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daridorexant.
The Daridorexant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daridorexant market comprehensively. Regional market sizes, concerning products by Type, by Application, by Dosage Form and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daridorexant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Dosage Form and by regions.
By Company
Idorsia
Simcere Pharmaceutical
Nxera Pharma
Segment by Type
25mg
50 mg
Segment by Dosage Form
Tablets
Other
Segment by Research Attributes
Original Drug
Generic Drug
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daridorexant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daridorexant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Daridorexant Market Overview
1.1 Product Definition
1.2 Daridorexant by Type
1.2.1 Global Daridorexant Market Value Comparison by Type (2024 VS 2031)
1.2.2 25mg
1.2.3 50 mg
1.3 Daridorexant by Dosage Form
1.3.1 Global Daridorexant Market Value Comparison by Dosage Form: 2024 VS 2031
1.3.2 Tablets
1.3.3 Other
1.4 Daridorexant by Research Attributes
1.4.1 Global Daridorexant Market Value Comparison by Research Attributes: 2024 VS 2031
1.4.2 Original Drug
1.4.3 Generic Drug
1.5 Daridorexant by Application
1.5.1 Global Daridorexant Market Value by Application (2024 VS 2031)
1.5.2 Hospital and Clinic
1.5.3 Retail Pharmacies
1.5.4 Other
1.6 Global Daridorexant Market Size Estimates and Forecasts
1.6.1 Global Daridorexant Revenue 2020-2031
1.6.2 Global Daridorexant Sales 2020-2031
1.6.3 Global Daridorexant Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Daridorexant Market Competition by Manufacturers
2.1 Global Daridorexant Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daridorexant Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daridorexant Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daridorexant, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daridorexant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daridorexant, Product Type & Application
2.7 Global Key Manufacturers of Daridorexant, Date of Enter into This Industry
2.8 Global Daridorexant Market Competitive Situation and Trends
2.8.1 Global Daridorexant Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daridorexant Players Market Share by Revenue
2.8.3 Global Daridorexant Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daridorexant Market Scenario by Region
3.1 Global Daridorexant Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daridorexant Sales by Region: 2020-2031
3.2.1 Global Daridorexant Sales by Region: 2020-2025
3.2.2 Global Daridorexant Sales by Region: 2026-2031
3.3 Global Daridorexant Revenue by Region: 2020-2031
3.3.1 Global Daridorexant Revenue by Region: 2020-2025
3.3.2 Global Daridorexant Revenue by Region: 2026-2031
3.4 North America Daridorexant Market Facts & Figures by Country
3.4.1 North America Daridorexant Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daridorexant Sales by Country (2020-2031)
3.4.3 North America Daridorexant Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Daridorexant Market Facts & Figures by Country
3.5.1 Europe Daridorexant Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daridorexant Sales by Country (2020-2031)
3.5.3 Europe Daridorexant Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daridorexant Market Facts & Figures by Region
3.6.1 Asia Pacific Daridorexant Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daridorexant Sales by Region (2020-2031)
3.6.3 Asia Pacific Daridorexant Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Daridorexant Market Facts & Figures by Country
3.7.1 Latin America Daridorexant Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daridorexant Sales by Country (2020-2031)
3.7.3 Latin America Daridorexant Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Daridorexant Market Facts & Figures by Country
3.8.1 Middle East and Africa Daridorexant Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daridorexant Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daridorexant Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daridorexant Sales by Type (2020-2031)
4.1.1 Global Daridorexant Sales by Type (2020-2025)
4.1.2 Global Daridorexant Sales by Type (2026-2031)
4.1.3 Global Daridorexant Sales Market Share by Type (2020-2031)
4.2 Global Daridorexant Revenue by Type (2020-2031)
4.2.1 Global Daridorexant Revenue by Type (2020-2025)
4.2.2 Global Daridorexant Revenue by Type (2026-2031)
4.2.3 Global Daridorexant Revenue Market Share by Type (2020-2031)
4.3 Global Daridorexant Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daridorexant Sales by Application (2020-2031)
5.1.1 Global Daridorexant Sales by Application (2020-2025)
5.1.2 Global Daridorexant Sales by Application (2026-2031)
5.1.3 Global Daridorexant Sales Market Share by Application (2020-2031)
5.2 Global Daridorexant Revenue by Application (2020-2031)
5.2.1 Global Daridorexant Revenue by Application (2020-2025)
5.2.2 Global Daridorexant Revenue by Application (2026-2031)
5.2.3 Global Daridorexant Revenue Market Share by Application (2020-2031)
5.3 Global Daridorexant Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Idorsia
6.1.1 Idorsia Company Information
6.1.2 Idorsia Description and Business Overview
6.1.3 Idorsia Daridorexant Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Idorsia Daridorexant Product Portfolio
6.1.5 Idorsia Recent Developments/Updates
6.2 Simcere Pharmaceutical
6.2.1 Simcere Pharmaceutical Company Information
6.2.2 Simcere Pharmaceutical Description and Business Overview
6.2.3 Simcere Pharmaceutical Daridorexant Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Simcere Pharmaceutical Daridorexant Product Portfolio
6.2.5 Simcere Pharmaceutical Recent Developments/Updates
6.3 Nxera Pharma
6.3.1 Nxera Pharma Company Information
6.3.2 Nxera Pharma Description and Business Overview
6.3.3 Nxera Pharma Daridorexant Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nxera Pharma Daridorexant Product Portfolio
6.3.5 Nxera Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daridorexant Industry Chain Analysis
7.2 Daridorexant Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daridorexant Production Mode & Process Analysis
7.4 Daridorexant Sales and Marketing
7.4.1 Daridorexant Sales Channels
7.4.2 Daridorexant Distributors
7.5 Daridorexant Customer Analysis
8 Daridorexant Market Dynamics
8.1 Daridorexant Industry Trends
8.2 Daridorexant Market Drivers
8.3 Daridorexant Market Challenges
8.4 Daridorexant Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Daridorexant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Daridorexant Market Value by Dosage Form, (US$ Million) & (2024 VS 2031)
Table 3. Global Daridorexant Market Value by Research Attributes, (US$ Million) & (2024 VS 2031)
Table 4. Global Daridorexant Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Daridorexant Market Competitive Situation by Manufacturers in 2024
Table 6. Global Daridorexant Sales (K Units) of Key Manufacturers (2020-2025)
Table 7. Global Daridorexant Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Daridorexant Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Daridorexant Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Daridorexant Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Daridorexant, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Daridorexant, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Daridorexant, Product Type & Application
Table 14. Global Key Manufacturers of Daridorexant, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Daridorexant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daridorexant as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Daridorexant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Daridorexant Sales by Region (2020-2025) & (K Units)
Table 20. Global Daridorexant Sales Market Share by Region (2020-2025)
Table 21. Global Daridorexant Sales by Region (2026-2031) & (K Units)
Table 22. Global Daridorexant Sales Market Share by Region (2026-2031)
Table 23. Global Daridorexant Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Daridorexant Revenue Market Share by Region (2020-2025)
Table 25. Global Daridorexant Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Daridorexant Revenue Market Share by Region (2026-2031)
Table 27. North America Daridorexant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Daridorexant Sales by Country (2020-2025) & (K Units)
Table 29. North America Daridorexant Sales by Country (2026-2031) & (K Units)
Table 30. North America Daridorexant Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Daridorexant Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Daridorexant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Daridorexant Sales by Country (2020-2025) & (K Units)
Table 34. Europe Daridorexant Sales by Country (2026-2031) & (K Units)
Table 35. Europe Daridorexant Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Daridorexant Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Daridorexant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Daridorexant Sales by Region (2020-2025) & (K Units)
Table 39. Asia Pacific Daridorexant Sales by Region (2026-2031) & (K Units)
Table 40. Asia Pacific Daridorexant Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Daridorexant Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Daridorexant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Daridorexant Sales by Country (2020-2025) & (K Units)
Table 44. Latin America Daridorexant Sales by Country (2026-2031) & (K Units)
Table 45. Latin America Daridorexant Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Daridorexant Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Daridorexant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Daridorexant Sales by Country (2020-2025) & (K Units)
Table 49. Middle East and Africa Daridorexant Sales by Country (2026-2031) & (K Units)
Table 50. Middle East and Africa Daridorexant Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Daridorexant Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Daridorexant Sales (K Units) by Type (2020-2025)
Table 53. Global Daridorexant Sales (K Units) by Type (2026-2031)
Table 54. Global Daridorexant Sales Market Share by Type (2020-2025)
Table 55. Global Daridorexant Sales Market Share by Type (2026-2031)
Table 56. Global Daridorexant Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Daridorexant Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Daridorexant Revenue Market Share by Type (2020-2025)
Table 59. Global Daridorexant Revenue Market Share by Type (2026-2031)
Table 60. Global Daridorexant Price (US$/Unit) by Type (2020-2025)
Table 61. Global Daridorexant Price (US$/Unit) by Type (2026-2031)
Table 62. Global Daridorexant Sales (K Units) by Application (2020-2025)
Table 63. Global Daridorexant Sales (K Units) by Application (2026-2031)
Table 64. Global Daridorexant Sales Market Share by Application (2020-2025)
Table 65. Global Daridorexant Sales Market Share by Application (2026-2031)
Table 66. Global Daridorexant Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Daridorexant Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Daridorexant Revenue Market Share by Application (2020-2025)
Table 69. Global Daridorexant Revenue Market Share by Application (2026-2031)
Table 70. Global Daridorexant Price (US$/Unit) by Application (2020-2025)
Table 71. Global Daridorexant Price (US$/Unit) by Application (2026-2031)
Table 72. Idorsia Company Information
Table 73. Idorsia Description and Business Overview
Table 74. Idorsia Daridorexant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Idorsia Daridorexant Product
Table 76. Idorsia Recent Developments/Updates
Table 77. Simcere Pharmaceutical Company Information
Table 78. Simcere Pharmaceutical Description and Business Overview
Table 79. Simcere Pharmaceutical Daridorexant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Simcere Pharmaceutical Daridorexant Product
Table 81. Simcere Pharmaceutical Recent Developments/Updates
Table 82. Nxera Pharma Company Information
Table 83. Nxera Pharma Description and Business Overview
Table 84. Nxera Pharma Daridorexant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Nxera Pharma Daridorexant Product
Table 86. Nxera Pharma Recent Developments/Updates
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Daridorexant Distributors List
Table 90. Daridorexant Customers List
Table 91. Daridorexant Market Trends
Table 92. Daridorexant Market Drivers
Table 93. Daridorexant Market Challenges
Table 94. Daridorexant Market Restraints
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Authors List of This Report
List of Figures
Figure 1. Product Picture of Daridorexant
Figure 2. Global Daridorexant Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Daridorexant Market Share by Type: 2024 & 2031
Figure 4. 25mg Product Picture
Figure 5. 50 mg Product Picture
Figure 6. Global Daridorexant Market Value by Dosage Form, (US$ Million) & (2020-2031)
Figure 7. Global Daridorexant Market Share by Dosage Form: 2024 VS 2031
Figure 8. Tablets Product Picture
Figure 9. Other Product Picture
Figure 10. Global Daridorexant Market Value by Research Attributes, (US$ Million) & (2020-2031)
Figure 11. Global Daridorexant Market Share by Research Attributes: 2024 VS 2031
Figure 12. Original Drug Product Picture
Figure 13. Generic Drug Product Picture
Figure 14. Global Daridorexant Market Value by Application (2020-2031) & (US$ Million)
Figure 15. Global Daridorexant Market Share by Application: 2024 & 2031
Figure 16. Hospital and Clinic
Figure 17. Retail Pharmacies
Figure 18. Other
Figure 19. Global Daridorexant Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Daridorexant Market Size (2020-2031) & (US$ Million)
Figure 21. Global Daridorexant Sales (2020-2031) & (K Units)
Figure 22. Global Daridorexant Average Price (US$/Unit) & (2020-2031)
Figure 23. Daridorexant Report Years Considered
Figure 24. Daridorexant Sales Share by Manufacturers in 2024
Figure 25. Global Daridorexant Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest Daridorexant Players: Market Share by Revenue in Daridorexant in 2024
Figure 27. Daridorexant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global Daridorexant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America Daridorexant Sales Market Share by Country (2020-2031)
Figure 30. North America Daridorexant Revenue Market Share by Country (2020-2031)
Figure 31. United States Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe Daridorexant Sales Market Share by Country (2020-2031)
Figure 34. Europe Daridorexant Revenue Market Share by Country (2020-2031)
Figure 35. Germany Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Daridorexant Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific Daridorexant Revenue Market Share by Region (2020-2031)
Figure 42. China Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. China Taiwan Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Daridorexant Sales Market Share by Country (2020-2031)
Figure 50. Latin America Daridorexant Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Colombia Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Daridorexant Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Daridorexant Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Daridorexant Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Daridorexant by Type (2020-2031)
Figure 61. Global Revenue Market Share of Daridorexant by Type (2020-2031)
Figure 62. Global Daridorexant Price (US$/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of Daridorexant by Application (2020-2031)
Figure 64. Global Revenue Market Share of Daridorexant by Application (2020-2031)
Figure 65. Global Daridorexant Price (US$/Unit) by Application (2020-2031)
Figure 66. Daridorexant Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
